BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28482476)

  • 1. Schiff base bond-linked polysaccharide-doxorubicin conjugate for upregulated cancer therapy.
    Feng X; Li D; Han J; Zhuang X; Ding J
    Mater Sci Eng C Mater Biol Appl; 2017 Jul; 76():1121-1128. PubMed ID: 28482476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-acidity-labile polysaccharide-di-drugs conjugate for targeted cancer chemotherapy.
    Li D; Su T; Ma L; Yin F; Xu W; Ding J; Li Z
    Eur J Med Chem; 2020 Aug; 199():112367. PubMed ID: 32474350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Versatile preparation of intracellular-acidity-sensitive oxime-linked polysaccharide-doxorubicin conjugate for malignancy therapeutic.
    Xu W; Ding J; Xiao C; Li L; Zhuang X; Chen X
    Biomaterials; 2015 Jun; 54():72-86. PubMed ID: 25907041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of pH-responsive long-circulating polysaccharide-drug conjugate nanocarriers for antitumor applications.
    Zhang X; Li D; Huang J; Ou K; Yan B; Shi F; Zhang J; Zhang J; Pang J; Kang Y; Wu J
    J Mater Chem B; 2019 Jan; 7(2):251-264. PubMed ID: 32254550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid-sensitive dextran prodrug: A higher molecular weight makes a better efficacy.
    Li D; Han J; Ding J; Chen L; Chen X
    Carbohydr Polym; 2017 Apr; 161():33-41. PubMed ID: 28189244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pH-responsive glycolipid-like nanocarrier for optimising the time-dependent distribution of free chemical drugs in focal cells.
    Cheng B; Lu B; Liu X; Meng T; Tan Y; Zhu Y; Liu N; Yuan H; Huang X; Hu F
    Int J Pharm; 2017 Apr; 522(1-2):210-221. PubMed ID: 28259679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-responsive PEGylated prodrugs for targeted doxorubicin delivery.
    Xu M; Qian J; Liu X; Liu T; Wang H
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():341-7. PubMed ID: 25746279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.
    Yang S; Tang Z; Zhang D; Deng M; Chen X
    Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual stimuli polysaccharide nanovesicles for conjugated and physically loaded doxorubicin delivery in breast cancer cells.
    Pramod PS; Shah R; Jayakannan M
    Nanoscale; 2015 Apr; 7(15):6636-52. PubMed ID: 25797322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schiff base-containing dextran nanogel as pH-sensitive drug delivery system of doxorubicin: Synthesis and characterization.
    Su H; Zhang W; Wu Y; Han X; Liu G; Jia Q; Shan S
    J Biomater Appl; 2018 Aug; 33(2):170-181. PubMed ID: 29940809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pH-responsive prodrug delivery system self-assembled from acid-labile doxorubicin-conjugated amphiphilic pH-sensitive block copolymers.
    Huang X; Liao W; Xie Z; Chen D; Zhang CY
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():27-37. PubMed ID: 29853091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin crosslinked pH-sensitive nanoparticles for efficient delivery of doxorubicin.
    Li M; Tang Z; Lv S; Song W; Hong H; Jing X; Zhang Y; Chen X
    Biomaterials; 2014 Apr; 35(12):3851-64. PubMed ID: 24495487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Featured Article: Chemotherapeutic delivery using pH-responsive, affinity-based release.
    Cyphert EL; Fu AS; von Recum HA
    Exp Biol Med (Maywood); 2017 Apr; 242(7):692-699. PubMed ID: 28178856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH/Reduction Dual-Responsive Oxidized Alginate-Doxorubicin (mPEG-OAL-DOX/Cys) Prodrug Nanohydrogels: Effect of Complexation with Cyclodextrins.
    Zhou T; Li J; Jia X; Zhao X; Liu P
    Langmuir; 2018 Jan; 34(1):416-424. PubMed ID: 29237263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Simple Dual-pH Responsive Prodrug-Based Polymeric Micelles for Drug Delivery.
    Mao J; Li Y; Wu T; Yuan C; Zeng B; Xu Y; Dai L
    ACS Appl Mater Interfaces; 2016 Jul; 8(27):17109-17. PubMed ID: 27280955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Targeted Polysaccharide Prodrug Suppresses Orthotopic Hepatoma.
    Li D; Xu W; Li P; Ding J; Cheng Z; Chen L; Yan L; Chen X
    Mol Pharm; 2016 Dec; 13(12):4231-4235. PubMed ID: 27784155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One-Step "Click Chemistry"-Synthesized Cross-Linked Prodrug Nanogel for Highly Selective Intracellular Drug Delivery and Upregulated Antitumor Efficacy.
    Zhang Y; Ding J; Li M; Chen X; Xiao C; Zhuang X; Huang Y; Chen X
    ACS Appl Mater Interfaces; 2016 May; 8(17):10673-82. PubMed ID: 27077549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug binding rate regulates the properties of polysaccharide prodrugs.
    Li D; Ding J; Zhuang X; Chen L; Chen X
    J Mater Chem B; 2016 Aug; 4(30):5167-5177. PubMed ID: 32263515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amphipathic dextran-doxorubicin prodrug micelles for solid tumor therapy.
    Jin R; Guo X; Dong L; Xie E; Cao A
    Colloids Surf B Biointerfaces; 2017 Oct; 158():47-56. PubMed ID: 28667893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific delivery of doxorubicin through conjugation of pH-responsive peptide for overcoming drug resistance in cancer.
    Feng C; Rui M; Shen H; Xin Y; Zhang J; Li J; Yue L; Lai W; Xu X
    Int J Pharm; 2017 Aug; 528(1-2):322-333. PubMed ID: 28606508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.